Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.
Lerner SP, Tangen C, Svatek RS, Daneshmand S, Pohar KS, Skinner E, Schuckman A, Sagalowsky AI, Smith ND, Kamat AM, Kassouf W, Plets M, Bangs R, Koppie TM, Alva A, La Rosa FG, Pal SK, Kibel AS, Canter DJ, Thompson IM Jr; SWOG S1011 Trial Investigators.
N Engl J Med. 2024 Oct 3;391(13):1206-1216. doi: 10.1056/NEJMoa2401497.
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial.
Touijer KA, Sjoberg DD, Benfante N, Laudone VP, Ehdaie B, Eastham JA, Scardino PT, Vickers A.
Eur Urol Oncol. 2021 Aug;4(4):532-539. doi: 10.1016/j.euo.2021.03.006. Epub 2021 Apr 15.
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
Touijer KA, Vertosick EA, Sjoberg DD, Liso N, Nalavenkata S, Melao B, Laudone VP, Ehdaie B, Carver B, Eastham JA, Scardino PT, Vickers AJ.
Eur Urol. 2025 Feb;87(2):253-260. doi: 10.1016/j.eururo.2024.10.006. Epub 2024 Oct 29.
Laterally extended parametrectomy.
Căpîlna ME, Ungár L, Cozlea AL, Gheorghe M, Stanca M, Lintner B, Moldovan AA.
Obstet Gynecol Sci. 2021 Sep;64(5):470-472. doi: 10.5468/ogs.21103. Epub 2021 May 25.
Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus After Robot-Assisted Laparoscopic Radical Cystectomy.
Wang S, Zhang D, Bai Y, Liu F, Qi X, Xie L.
J Laparoendosc Adv Surg Tech A. 2023 Aug;33(8):776-781. doi: 10.1089/lap.2023.0118. Epub 2023 Jun 1.
[Surgical technique of axillary, inguinal and iliac lymph node dissection].
Vlasenko D.
Chirurgie (Heidelb). 2023 Feb;94(2):121-129. doi: 10.1007/s00104-022-01768-8. Epub 2022 Nov 30.
Variation in Lymph Node Yield After Radical Cystectomy.
Faraj KS, Judge N, Chang YH, Blodgett G, Stanton ML, Tyson MD.
Am J Clin Pathol. 2021 Aug 4;156(3):391-398. doi: 10.1093/ajcp/aqaa247.
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, Cordeiro MD, Sarkis AS, Faraj SF, Mitre AI, Srougi M, Nahas WC.
Eur Urol. 2021 May;79(5):595-604. doi: 10.1016/j.eururo.2020.11.040. Epub 2020 Dec 5.
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis.
Hinojosa-Gonzalez DE, Nolazco JI, Saffati G, Kronstedt S, Jones JA, Kadmon D, Badal J, Slawin JR.
Eur Urol Focus. 2024 Mar;10(2):234-241. doi: 10.1016/j.euf.2024.01.002. Epub 2024 Jan 18.
Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine.
Afferi L, Spahn M, Hayoz S, Strebel RT, Rothschild SI, Seifert H, Özdemir BC, Kiss B, Maletzki P, Engeler D, Wirth G, Hadaschik B, Lucca I, John H, Sauer A, Müntener M, Bubendorf L, Schneider M, Musilova J, Petrausch U, Cathomas R; Swiss Group for Clinical Cancer Research (SAKK).
BJU Int. 2024 Sep;134(3):388-397. doi: 10.1111/bju.16318. Epub 2024 Mar 8.
